In A Prescription for Change, Michael Kinch, associate vice chancellor and director of the Center for Research Innovation in Biotechnology, tells about the looming crisis in the pharmaceutical industry. Bringing a drug to market costs $2.6 billion, and most pharmaceutical companies have shut down their research and development wings as a result. To keep new drugs coming to market, Kinch argues, we must find ways to lower the cost of producing them.
A Prescription for Change
The Looming Crisis in Drug Development